Non-Communicable Diseases (NCDs) —including cardiovascular diseases, diabetes, obesity, cancer, and chronic respiratory conditions — create an enormous impact on health systems, economies, and societies.
The Health for All initiative provides a unique, multi-stakeholder environment for global leaders to create a new global health architecture, designed to address the long-term burden placed on health systems from NCDs. We believe that public health innovation can be supported through effective public-private partnerships, innovative financing models, and a commitment to ensure no community is left behind.
Three key priorities define how the Health For All Initiative enables impact

Make the business and societal case for chronic disease prevention and care management to unlock resources critical to underserved populations and apply innovations and resources across the care pathway for every diseases

Engage governments to embrace new models of public health that focus on availability, access, and affordability for prevention and care across all populations and diseases

Architect new governance models that empower public-private partnerships to operate with accountability and drive impact across national and community programmes
Three systemic gaps are driving where public-private partnerships and innovation are needed to create sustainable change across health systems.
Identify the new funding models that enable holisic prevention and integrated care across chronic diseases, especially in Low- and Middle-Income Countries
Link early action on NCDs to economic growth and workforce productivity, informing policy makers on how to best allocate resources and coordinate with international organisations, civil socieities, NGOs, and the private sector
Leverage data insights to accelerate how Public-Private Partnerships can enhance education, screening, diagnosis, and treatments to drive better health outcomes, starting with Cardiometabolic Health
The paper provides policy-ready guidance to help governments, healthcare leaders, employers, investors, payers and the health industry to translate the growing recognition of rare diseases into coordinated action.
Health For All Initiative
A World Economic Forum Initiative